SEROTONINERGIC MECHANISMS IN HYPERTENSION - FOCUS ON THE EFFECTS OF KETANSERIN

被引：116

作者：

VANHOUTTE, P

AMERY, A

BIRKENHAGER, W

BRECKENRIDGE, A

BUHLER, F

DISTLER, A

DORMANDY, J

DOYLE, A

FROHLICH, E

HANSSON, L

HEDNER, T

HOLLENBERG, N

JENSEN, HE

LUNDJOHANSEN, P

MEYER, P

OPIE, L

ROBERTSON, I

SAFAR, M

SCHALEKAMP, M

SYMOENS, J

TRAPJENSEN, J

ZANCHETTI, A

机构：

[1] CATHOLIC UNIV LEUVEN,LIEKENHUIS GASTHUISBERG,B-3000 LOUVAIN,BELGIUM

[2] UNIV LIVERPOOL,LIVERPOOL L69 3BX,ENGLAND

[3] FREE UNIV BERLIN,KLINIKUM STEGLITZ,D-1000 BERLIN 45,FED REP GER

[4] ST JAMES HOSP,LONDON SW12 8HW,ENGLAND

[5] UNIV MELBOURNE,DEPT PHYSIOL,PARKVILLE,VIC 3052,AUSTRALIA

[6] ALTON OCHSNER MED FDN & OCHSNER CLIN,NEW ORLEANS,LA 70121

[7] GOTHENBURG UNIV,DEPT CLIN PHARMACOL,S-41124 GOTHENBURG,SWEDEN

[8] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115

[9] HVIDOVRE HOSP,DEPT DIALYSIS,DK-2650 HVIDOVRE,DENMARK

[10] HAUKELAND HOSP,DEPT INTERNAL MED,N-5016 BERGEN,NORWAY

[11] HOP NECKER ENFANTS MALAD,DEPT PHARMACOL,F-75730 PARIS 15,FRANCE

[12] UNIV CAPE TOWN,DEPT MED,CAPE TOWN,SOUTH AFRICA

[13] WESTERN INFIRM,BLOOD PRESSURE UNIT,GLASGOW G11 6NT,SCOTLAND

[14] HOP BROUSSAIS,F-75674 PARIS 14,FRANCE

[15] JANSSEN PHARMACEUT,DEPT CLIN RES,B-2340 BEERSE,BELGIUM

[16] FREDERIKSBERG HOSP,DEPT PHYSIOL,DK-2000 COPENHAGEN,DENMARK

[17] UNIV MILAN,CTR PHYSIOL CLIN & IPERTENS,IST CLIN MED GEN,I-20122 MILAN,ITALY

[18] ZUIDERZIEKENHUIS,DEPT INTERNAL MED,ROTTERDAM,NETHERLANDS

[19] UNIV KLIN BASEL,KANTONSSPITAL,BASEL,SWITZERLAND

[20] OSTRA HOSP,DEPT MED,GOTEBORG,SWEDEN

[21] AKAD ZIEKENHUIS DIJKZIGT,ROTTERDAM,NETHERLANDS

来源：

HYPERTENSION | 1988年 / 11卷 / 02期

关键词：

D O I：

10.1161/01.HYP.11.2.111

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：111 / 133

页数：23

共 325 条

[121]

HEDNER T, 1985, J CARDIOVASC PHARM, V7, pS161

[122]

HEDNER T, 1986, J HYPERTENS, V4, pS91

[123]

HEDNER T, 1985, J CARDIOVASC PHARM, V7, pS148

[124] KETANSERIN, A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST - MONOTHERAPY IN ESSENTIAL-HYPERTENSION [J].

HEDNER, T ;

PERSSON, B ;

BERGLUND, G .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :121-125

[125] KETANSERIN IN COMBINATION WITH BETA-ADRENERGIC-RECEPTOR BLOCKING-AGENTS IN THE TREATMENT OF ESSENTIAL-HYPERTENSION [J].

HEDNER, T ;

PERSSON, B .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (05) :765-771

[126] CARDIOVASCULAR EFFECTS OF KETANSERIN DURING COLD PRESSURE AND DURING ISOMETRIC AND DYNAMIC EXERCISE IN HYPERTENSIVE PATIENTS [J].

HEDNER, T ;

ANDERSSON, OK ;

PETTERSSON, A ;

PERSSON, B .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 :S73-S77

[127] EXPERIENCE WITH KETANSERIN, A SEROTONIN (S2) ANTAGONIST, IN LONGTERM TREATMENT OF ESSENTIAL-HYPERTENSION [J].

HEDNER, T ;

PERSSON, B ;

BERGLUND, G .

CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1984, 6 (03) :743-751

[128]

HEDNER T, 1986, 10TH WORLD C CARD IN, P194

[129]

HEISTAD DD, 1986, J HYPERTENS, V4, pS17

[130] AUGMENTED RESPONSES TO VASOCONSTRICTOR STIMULI IN HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC MONKEYS [J].

HEISTAD, DD ;

ARMSTRONG, ML ;

MARCUS, ML ;

PIEGORS, DJ ;

MARK, AL .

CIRCULATION RESEARCH, 1984, 54 (06) :711-718

← 8 9 10 11 12 13 14 15 16 17 →